| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000007820 |
| Receipt No. | R000001265 |
| Official scientific title of the study | A Randamized, Prospective and Comparative Study of Topical Timolol and Latanoprost in Uveitic Glaucoma |
| Date of disclosure of the study information | 2012/04/23 |
| Last modified on | 2018/04/28 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | A Randamized, Prospective and Comparative Study of Topical Timolol and Latanoprost in Uveitic Glaucoma | |
| Title of the study (Brief title) | A Comparative Study of Topical Timolol and Latanoprost in Uveitic Glaucoma | |
| Region |
|
|
| Condition | ||
| Condition | Uveitic Glaucoma
|
|
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We evaluated effects on the intraocular pressure (IOP) lowering and safety of topical timolol and latanoprost in UG prospectively. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | intraocular pressure-lowering ratio
|
| Key secondary outcomes | 1)flare value in the anterior chamber
2)side effects(conjunctival injection, corneal erosion) 3)macular thickness measured by OCT |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | YES |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Latanoprost eye drop
|
|
| Interventions/Control_2 | Timolol-XE eye drop | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)The patients received topical corticosteroid for uveitis.
2) There was no strong inflammation in the anterior chamber within these 3 months. 3) The objective eyes didn't received anti-glaucoma eye drops. 4) 30mmHg> Baseline IOP (before starting treatment) >=21mmHg |
|||
| Key exclusion criteria | 1) herpetic iritis
2) PAS index>25% (secondary angle closure glaucoma) 3) The patients who received Argon Laser Trabeculoplasty within 3 months. 4) The patients who received intraocular surgeries within 6 months. 5)The patients who had asthma or arrythmia, and couldn't receive timolol. |
|||
| Target sample size | 120 | |||
| Research contact person | |
| Name of lead principal investigator | Toshikatsu Kaburaki |
| Organization | University of Tokyo Hospital |
| Division name | Ophthalmology |
| Address | 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan |
| TEL | 03-3815-5411 |
| kabutosi-tky@umin.ac.jp | |
| Public contact | |
| Name of contact person | Toshikatsu Kaburaki |
| Organization | University of Tokyo Hospital |
| Division name | Ophthalmology |
| Address | 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan |
| TEL | 03-3815-5411 |
| Homepage URL | |
| kabutosi-tky@umin.ac.jp | |
| Sponsor | |
| Institute | Deportment of Ophthalmology, University of Tokyo Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Deportment of Ophthalmology, University of Tokyo Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Department of Ophthalmology, Teikyo University Hospital
|
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東京大学附属病院眼科(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000001265 |